These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12939549)

  • 1. Intravenous indomethacin therapy in infants with a patent ductus arteriosus complicating other congenital heart defects.
    Watanabe K; Tomita H; Ono Y; Yamada O; Kurosaki K; Echigo S
    Circ J; 2003 Sep; 67(9):750-2. PubMed ID: 12939549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimal effective dose of indomethacin for the treatment of patent ductus arteriosus in preterm infants.
    Dumas de la Roque E; Fayon M; Babre F; Demarquez JL; Pedespan L
    Biol Neonate; 2002; 81(2):91-4. PubMed ID: 11844876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic indomethacin reduces grades III and IV intraventricular hemorrhages when compared to early indomethacin treatment of a patent ductus arteriosus.
    Yanowitz TD; Baker RW; Sobchak Brozanski B
    J Perinatol; 2003 Jun; 23(4):317-22. PubMed ID: 12774141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral indomethacin versus oral ibuprofen for treatment of patent ductus arteriosus: a randomised controlled study in very low-birthweight infants.
    Khuwuthyakorn V; Jatuwattana C; Silvilairat S; Tantiprapha W
    Paediatr Int Child Health; 2018 Aug; 38(3):187-192. PubMed ID: 29912679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital heart disease in low birth weight infants.
    Levin DL; Stanger P; Kitterman JA; Heymann MA
    Circulation; 1975 Sep; 52(3):500-3. PubMed ID: 1157251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of outcome in 298 extremely low-birth-weight infants with patent ductus arteriosus.
    Alexander F; Chiu L; Kroh M; Hammel J; Moore J
    J Pediatr Surg; 2009 Jan; 44(1):112-7; disscusion 117. PubMed ID: 19159727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is oral indomethacin effective in treatment of preterm infants with patent ductus arteriosus?
    Satar M; Yapicioğlu H; Narli N; Ozbarlas N; Küçükosmanoğlu O; Tutak E
    Turk J Pediatr; 2004; 46(2):137-41. PubMed ID: 15214742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with permanent closure of the ductus arteriosus: a role for prolonged indomethacin therapy.
    Quinn D; Cooper B; Clyman RI
    Pediatrics; 2002 Jul; 110(1 Pt 1):e10. PubMed ID: 12093991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late closure of the ductus arteriosus using indomethacin in the preterm infant.
    Kresch MJ; Moya FR; Ascuitto RJ; Ross-Ascuitto NT; Heusser F
    Clin Pediatr (Phila); 1988 Mar; 27(3):140-3. PubMed ID: 3342597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of patent ductus arteriosus and subsequent therapy with indomethacin on cerebral oxygenation in preterm infants.
    Lemmers PM; Toet MC; van Bel F
    Pediatrics; 2008 Jan; 121(1):142-7. PubMed ID: 18166568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Placebo, Indomethacin, Ibuprofen, and Acetaminophen With Closure of Hemodynamically Significant Patent Ductus Arteriosus in Preterm Infants: A Systematic Review and Meta-analysis.
    Mitra S; Florez ID; Tamayo ME; Mbuagbaw L; Vanniyasingam T; Veroniki AA; Zea AM; Zhang Y; Sadeghirad B; Thabane L
    JAMA; 2018 Mar; 319(12):1221-1238. PubMed ID: 29584842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants.
    Chotigeat U; Jirapapa K; Layangkool T
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S563-9. PubMed ID: 14700149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent Doppler flow predicts lack of response to multiple courses of indomethacin in premature infants with recurrent patent ductus arteriosus.
    Keller RL; Clyman RI
    Pediatrics; 2003 Sep; 112(3 Pt 1):583-7. PubMed ID: 12949288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patent ductus arteriosus, indomethacin and necrotizing enterocolitis in very low birth weight infants: a population-based study.
    Dollberg S; Lusky A; Reichman B
    J Pediatr Gastroenterol Nutr; 2005 Feb; 40(2):184-8. PubMed ID: 15699694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orogastric and intravenous indomethacin administration to very premature neonates with patent ductus arteriosus: population pharmacokinetics, absolute bioavailability, and treatment outcome.
    Al Za'abi M; Donovan T; Tudehope D; Woodgate P; Collie LA; Charles B
    Ther Drug Monit; 2007 Dec; 29(6):807-14. PubMed ID: 18043480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-type natriuretic peptide predicts responses to indomethacin in premature neonates with patent ductus arteriosus.
    Hsu JH; Yang SN; Chen HL; Tseng HI; Dai ZK; Wu JR
    J Pediatr; 2010 Jul; 157(1):79-84. PubMed ID: 20227723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants.
    Jaillard S; Larrue B; Rakza T; Magnenant E; Warembourg H; Storme L
    Ann Thorac Surg; 2006 Jan; 81(1):231-4. PubMed ID: 16368371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus.
    Van Overmeire B; Smets K; Lecoutere D; Van de Broek H; Weyler J; Degroote K; Langhendries JP
    N Engl J Med; 2000 Sep; 343(10):674-81. PubMed ID: 10974130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous indometacin in preterm infants with symptomatic patent ductus arteriosus. A population pharmacokinetic study.
    Smyth JM; Collier PS; Darwish M; Millership JS; Halliday HL; Petersen S; McElnay JC
    Br J Clin Pharmacol; 2004 Sep; 58(3):249-58. PubMed ID: 15327584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical aspects of very-low-birthweight infants showing reopening of ductus arteriosus.
    Uchiyama A; Nagasawa H; Yamamoto Y; Tatebayashi K; Suzuki H; Yamada K; Arai M; Kohno Y
    Pediatr Int; 2011 Jun; 53(3):322-7. PubMed ID: 20854286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.